Proteome Sciences

Proteome Sciences

Biotechnology, Cobham, Missouri, 65712, United States, 11-50 Employees

proteomics.com

  • twitter
  • LinkedIn

phone no Phone Number: +19*********

Who is PROTEOME SCIENCES

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for th...

Read More

map
  • Cobham, Missouri, 65712, United States Headquarters: Cobham, Missouri, 65712, United States
  • 1995 Date Founded: 1995
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 4941

checked-icon Does something look wrong? Fix it. | View contact records from PROTEOME SCIENCES

Proteome Sciences Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Proteome Sciences

Answer: Proteome Sciences's headquarters are located at Cobham, Missouri, 65712, United States

Answer: Proteome Sciences's phone number is +19*********

Answer: Proteome Sciences's official website is https://proteomics.com

Answer: Proteome Sciences's revenue is Under $1 Million

Answer: Proteome Sciences's SIC: 4941

Answer: Proteome Sciences has 11-50 employees

Answer: Proteome Sciences is in Biotechnology

Answer: Proteome Sciences contact info: Phone number: +19********* Website: https://proteomics.com

Answer: Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant and TMTMS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibratorTM provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available. We have discovered and patented a large number of novel protein biomarkers for diagnosis, prognosis and treatment of key human diseases including neurodegenerative disorders, cancer, stroke etc. and provide protein biomarker services to pharmaceutical and diagnostics companies. We have wide experience across the life sciences sector working with many different human and animal sample types including blood plasma, CSF, solid tissues, cell culture material etc. As a reflection of the quality of our approach, the purpose built, state-of-the-art research facility in Frankfurt is certified to ISO 9001:2015 and GCLP

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access